HIGHLIGHTS
- who: Vepusha Sathanantham et al. from the Department Clinical Chemistry, Inselspital, Bern University Hospital, Bern, Switzerland have published the research: Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study, in the Journal: Life 2022, 12, x FOR PEER REVIEW of /2022/
- what: In a prospective multicenter cross-sectional study including 851 patients the authors aimed to study the accuracy PiCT in determining rivaroxaban apixaban and edoxaban drug concentrations and assessed whether clinically relevant PiCT was utilized. The authors aimed to assess whether clinically relevant . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.